Literature DB >> 8903657

Midwall left ventricular performance in salt-loaded Dahl rats: effect of AT1 angiotensin II inhibition.

G de Simone1, R B Devereux, M J Camargo, D C Wallerson, J E Sealey, J H Laragh.   

Abstract

OBJECTIVE: The relationship between left ventricular midwall shortening and circumferential end-systolic stress was studied in Dahl salt-sensitive (Dahl S) and salt-resistant (Dahl R) rats after 6-8 weeks of an 8% Na+ diet with or without losartan, an AT1 angiotensin II receptor antagonist.
MATERIALS AND METHODS: Losartan was given in drinking water to 13 Dahl S and 13 Dahl R rats, while 14 control Dahl S and 14 control Dahl R rats were given tap water, for 8 weeks. The endpoint was the last blood pressure and echocardiographic examination after 8 weeks or before death for rats which did not survive the entire period. Tail blood pressure was measured in awake animals and two-dimensional guided M-mode echocardiography was used.
RESULTS: The left ventricular midwall shortening-circumferential end-systolic stress relationship in 45 normotensive Wistar rats was used to calculate the ratio of observed to predicted left ventricular midwall fractional shortening. At the endpoint, afterload-independent midwall shortening was higher in Dahl S rats on losartan or tap water, and in Dahl R rats on losartan than in weight-matched normotensive Wistar rats (all P<0.05). Afterload-independent midwall shortening was related to the left ventricular chamber dimension in a learning series of 109 rats (64 Goldblatt and 45 normotensive rats on a normal sodium diet; r = 0.73) and was adjusted in Dahl rats to a constant left ventricular internal diameter (6.9 mm) by the learning regression equation. The adjusted afterload-independent midwall shortening was still higher in Dahl S rats on losartan than in controls (P<0.02). Left ventricular internal diameter-adjusted afterload-independent midwall shortening was inversely related to the left ventricular mass in both Dahl S and Dahl R groups (r = -0.40 and -0.72, both P<0.04).
CONCLUSIONS: (1) Midwall left ventricular performance was higher in Dahl S than Dahl R rats on a high-salt diet; (2) this elevation was partially independent of an increase in left ventricular chamber size, an indirect measure of preload; and (3) in Dahl S rats on losartan, increased left ventricular performance is related to improved contractility, associated with a blunted development of left ventricular hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8903657

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Effects of combined therapy of Xuezhikang Capsule and Valsartan on hypertensive left ventricular hypertrophy and heart rate turbulence.

Authors:  Chun Gong; Shao-lie Huang; Jian-feng Huang; Zhi-fang Zhang; Ming Luo; Yu Zhao; Xiao-jie Jiang
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

Review 2.  Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension.

Authors:  K L Goa; A J Wagstaff
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

3.  Gender differences in diastolic function among youth.

Authors:  G K Kapuku; H C Davis; N Shah; A M McMillan; G A Harshfield
Journal:  Pediatr Cardiol       Date:  2007-09-25       Impact factor: 1.655

4.  Chronic intake of a phytochemical-enriched diet reduces cardiac fibrosis and diastolic dysfunction caused by prolonged salt-sensitive hypertension.

Authors:  E M Seymour; Andrew A M Singer; Maurice R Bennink; Rushi V Parikh; Ara Kirakosyan; Peter B Kaufman; Steven F Bolling
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-10       Impact factor: 6.053

5.  Effects of Race, Cardiac Mass, and Cardiac Load on Myocardial Function Trajectories from Childhood to Young Adulthood: The Augusta Heart Study.

Authors:  Gaston Kapuku; Melissa Howie; Santu Ghosh; Vishal Doshi; Michael Bykhovsky; Brittany Ange; James D Halbert; Vincent Robinson; Zsolt Bagi; Gregory Harshfield; Varghese George
Journal:  J Am Heart Assoc       Date:  2021-01-18       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.